// App-Quantinova.ai

: Efficacy and Safety of Nelarabine in Different Age Groups with T-Cell Hematological Malignancies: A Systematic Review of Clinical Trials

Researchers

Presenter

  • Wajeeha Aiman

Principal Investigators

  • Zainab Omar

  • Muhammad Saad Anwar

  • Sarah Sarwat Uzma Munawar

  • Sumaiya Asfund

  • Yusra Arooj

  • Shadma Fatima

  • Hina Zubair

  • Huda Khan

  • Rabiya Niaz

  • Taimoor Jamil

  • Ayesha Anwar

  • Muhammad Ashar Ali

Medical Centers

  • University of Southern California, Los Angeles, CA

  • Prime Health Care Consortium at Saint Clare's and Saint Mary's Hospital, Denville, NJ

  • NHS General Practitioner, East Berkshire CCG, Berkshire, United Kingdom

  • University of New South Wales, Sydney, Australia

  • Dubai Medical College for Girls, Dubai, United Arab Emirates

  • Jinnah Sindh Medical University, Karachi, Pakistan

  • King Edward Medical University, Lahore, Pakistan

  • Internal Medicine, Saint Michael's Medical Center, Newark, NJ

  • Guthrie/ Robert Packer Hospital, Sayre, PA

  • Rawalpindi Medical University, Rawalpindi, Pakistan

  • St. Louis County Department of Public Health, Saint Louis, MO

Locations

  • United States

  • Australia

  • Pakistan

  • United Arab Emirates

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Hematological malignancies

  • Lymphomas

Biomarkers

  • N/A

Drug/Treatment

  • Nelarabine

Outcome

  • N/A

Study Design

  • Randomized

  • Efficacy

  • Safety

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved